FDA 483 - Paul Harmatz, M.D. - October 16, 2020
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Paul Harmatz, M.D. in Oakland, CA, a clinical investigator, revealed a significant issue with informed consent documentation. The inspection found that written informed consent forms were not properly signed by subjects or their legally authorized representatives, including instances where ad hoc translations were used without proper signatures or witness attestations. This indicates a failure to adhere to proper clinical trial documentation practices.
ID · 4be550aa-04d7-4658-a54a-258d02328940